The Montreal Cancer Institute is proud to recognize the excellence of Drs. Isabelle Bourdeau, Arielle Elkrief, Bertrand Routy, and Simon Turcotte, recipients of the Guy Lafleur Fund for Precision Medicine in Oncology, announced during the event “The Guy Lafleur Fund in Action!” organized by the CHUM Foundation.
These researchers, members of the Montreal Cancer Institute and the CHUM Research Centre, stand out for their innovative projects aimed at pushing the boundaries of oncology treatments.
A Collaboration Transforming Research
For decades, the Montreal Cancer Institute has been committed to funding both fundamental and clinical research to develop groundbreaking cancer treatments. By partnering with the CHUM Foundation for the Guy Lafleur Fund with a $500,000 donation, we support projects that represent the future of precision medicine, directly benefiting patients.
This collaboration highlights the power of collective efforts: philanthropic support transformed into scientific breakthroughs.
Other news
